InspireMD Historical Balance Sheet

NSPR Stock

USD 2.80 0.07 2.44%

Trend analysis of InspireMD balance sheet accounts such as Total Stockholder Equity of 37.9 M provides information on InspireMD's total assets, liabilities, and equity, which is the actual value of InspireMD to its prevalent stockholders. By breaking down trends over time using InspireMD balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining InspireMD latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether InspireMD is a good buy for the upcoming year.

InspireMD Inventory

2.7 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.

About InspireMD Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of InspireMD at a specified time, usually calculated after every quarter, six months, or one year. InspireMD Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of InspireMD and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which InspireMD currently owns. An asset can also be divided into two categories, current and non-current.

InspireMD Balance Sheet Chart

At this time, InspireMD's Total Current Assets are relatively stable compared to the past year. As of 03/19/2025, Short and Long Term Debt Total is likely to grow to about 2.6 M, though Net Debt is likely to grow to (16.3 M).

Total Assets Cash And Short Term Investments Deferred Long Term Asset Charges Capital Stock Capital Lease Obligations

Add Fundamental

Total Assets

Total assets refers to the total amount of InspireMD assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in InspireMD books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of InspireMD balance sheet. This account contains InspireMD investments that will expire within one year. These investments include stocks and bonds that can be liquidated by InspireMD fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Capital Stock

The total amount of a company's capital funded by shareholders through the issue and subscription of shares.

Capital Lease Obligations

InspireMD capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to InspireMD asset purchases. For example, InspireMD can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as InspireMD control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.

Most accounts from InspireMD's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into InspireMD current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.At this time, InspireMD's Total Current Assets are relatively stable compared to the past year. As of 03/19/2025, Short and Long Term Debt Total is likely to grow to about 2.6 M, though Net Debt is likely to grow to (16.3 M).

	2022	2023	2024	2025 (projected)
Other Current Liabilities	4.0M	4.5M	6.4M	6.7M
Total Assets	24.7M	47.6M	46.8M	49.1M

Other Current Liab Total Assets

InspireMD balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Non Current Liabilities Total	Inventory	Property Plant And Equipment Gross	Short Term Debt	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Accounts Payable
Total Assets		0.86	0.29	0.98	-0.75	-0.68	0.71	0.97	0.21	0.88	0.62	0.17	1.0	-0.34	-0.16	0.86	0.37	0.61	0.07	0.65	0.88	-0.3	0.66	0.86	-0.4	0.44
Other Current Liab	0.86		0.42	0.78	-0.62	-0.61	0.71	0.78	0.18	0.93	0.46	0.35	0.83	-0.16	0.03	0.94	0.47	0.63	0.19	0.82	0.93	-0.16	0.53	0.92	-0.26	0.38
Total Current Liabilities	0.29	0.42		0.14	0.08	-0.26	0.19	0.31	-0.16	0.33	0.3	0.71	0.29	-0.47	0.58	0.4	0.59	0.14	0.44	0.31	0.31	0.65	0.4	0.27	0.04	0.52
Total Stockholder Equity	0.98	0.78	0.14		-0.8	-0.72	0.64	0.96	0.2	0.85	0.68	-0.03	0.97	-0.34	-0.35	0.8	0.21	0.55	-0.1	0.57	0.85	-0.43	0.66	0.84	-0.48	0.37
Net Debt	-0.75	-0.62	0.08	-0.8		0.65	-0.79	-0.78	-0.09	-0.74	-0.58	0.17	-0.75	0.15	0.41	-0.73	-0.24	-0.56	0.05	-0.45	-0.75	0.5	-0.51	-0.74	0.55	-0.36
Retained Earnings	-0.68	-0.61	-0.26	-0.72	0.65		-0.34	-0.75	0.28	-0.73	-0.93	0.21	-0.65	0.62	0.42	-0.77	-0.17	-0.12	0.22	-0.18	-0.78	0.1	-0.85	-0.8	0.87	-0.21
Cash	0.71	0.71	0.19	0.64	-0.79	-0.34		0.66	0.14	0.67	0.23	0.39	0.71	-0.07	0.17	0.71	0.52	0.62	0.38	0.59	0.65	-0.24	0.31	0.64	-0.17	0.54
Cash And Short Term Investments	0.97	0.78	0.31	0.96	-0.78	-0.75	0.66		0.09	0.82	0.71	0.12	0.97	-0.46	-0.18	0.83	0.42	0.58	0.1	0.53	0.83	-0.24	0.73	0.81	-0.52	0.49
Common Stock Total Equity	0.21	0.18	-0.16	0.2	-0.09	0.28	0.14	0.09		0.01	-0.18	0.13	0.21	0.58	-0.09	0.04	0.08	0.42	0.12	0.59	0.04	-0.47	-0.06	0.08	0.41	0.02
Common Stock Shares Outstanding	0.88	0.93	0.33	0.85	-0.74	-0.73	0.67	0.82	0.01		0.58	0.1	0.85	-0.29	-0.2	0.93	0.29	0.57	-0.05	0.69	0.99	-0.18	0.54	0.95	-0.41	0.35
Other Stockholder Equity	0.62	0.46	0.3	0.68	-0.58	-0.93	0.23	0.71	-0.18	0.58		-0.19	0.61	-0.6	-0.45	0.63	0.19	0.06	-0.2	0.09	0.64	-0.16	0.92	0.66	-0.84	0.25
Total Liab	0.17	0.35	0.71	-0.03	0.17	0.21	0.39	0.12	0.13	0.1	-0.19		0.19	-0.01	0.9	0.22	0.76	0.29	0.84	0.39	0.07	0.41	0.06	0.04	0.39	0.49
Total Current Assets	1.0	0.83	0.29	0.97	-0.75	-0.65	0.71	0.97	0.21	0.85	0.61	0.19		-0.35	-0.14	0.82	0.38	0.62	0.1	0.63	0.84	-0.31	0.64	0.82	-0.38	0.48
Common Stock	-0.34	-0.16	-0.47	-0.34	0.15	0.62	-0.07	-0.46	0.58	-0.29	-0.6	-0.01	-0.35		-0.01	-0.33	-0.11	0.19	0.09	0.25	-0.29	-0.41	-0.58	-0.3	0.57	-0.29
Short Long Term Debt Total	-0.16	0.03	0.58	-0.35	0.41	0.42	0.17	-0.18	-0.09	-0.2	-0.45	0.9	-0.14	-0.01		-0.08	0.6	0.06	0.81	0.09	-0.24	0.6	-0.22	-0.28	0.49	0.36
Non Current Assets Total	0.86	0.94	0.4	0.8	-0.73	-0.77	0.71	0.83	0.04	0.93	0.63	0.22	0.82	-0.33	-0.08		0.49	0.58	0.16	0.68	0.96	-0.13	0.67	0.97	-0.48	0.4
Non Currrent Assets Other	0.37	0.47	0.59	0.21	-0.24	-0.17	0.52	0.42	0.08	0.29	0.19	0.76	0.38	-0.11	0.6	0.49		0.5	0.89	0.39	0.29	0.24	0.4	0.29	-0.06	0.55
Net Receivables	0.61	0.63	0.14	0.55	-0.56	-0.12	0.62	0.58	0.42	0.57	0.06	0.29	0.62	0.19	0.06	0.58	0.5		0.4	0.8	0.55	-0.35	0.07	0.51	0.17	0.57
Non Current Liabilities Total	0.07	0.19	0.44	-0.1	0.05	0.22	0.38	0.1	0.12	-0.05	-0.2	0.84	0.1	0.09	0.81	0.16	0.89	0.4		0.26	-0.06	0.26	0.04	-0.07	0.25	0.48
Inventory	0.65	0.82	0.31	0.57	-0.45	-0.18	0.59	0.53	0.59	0.69	0.09	0.39	0.63	0.25	0.09	0.68	0.39	0.8	0.26		0.68	-0.24	0.14	0.65	0.2	0.4
Property Plant And Equipment Gross	0.88	0.93	0.31	0.85	-0.75	-0.78	0.65	0.83	0.04	0.99	0.64	0.07	0.84	-0.29	-0.24	0.96	0.29	0.55	-0.06	0.68		-0.21	0.61	0.98	-0.47	0.31
Short Term Debt	-0.3	-0.16	0.65	-0.43	0.5	0.1	-0.24	-0.24	-0.47	-0.18	-0.16	0.41	-0.31	-0.41	0.6	-0.13	0.24	-0.35	0.26	-0.24	-0.21		-0.06	-0.25	0.16	0.02
Other Liab	0.66	0.53	0.4	0.66	-0.51	-0.85	0.31	0.73	-0.06	0.54	0.92	0.06	0.64	-0.58	-0.22	0.67	0.4	0.07	0.04	0.14	0.61	-0.06		0.66	-0.74	0.2
Property Plant And Equipment Net	0.86	0.92	0.27	0.84	-0.74	-0.8	0.64	0.81	0.08	0.95	0.66	0.04	0.82	-0.3	-0.28	0.97	0.29	0.51	-0.07	0.65	0.98	-0.25	0.66		-0.51	0.27
Current Deferred Revenue	-0.4	-0.26	0.04	-0.48	0.55	0.87	-0.17	-0.52	0.41	-0.41	-0.84	0.39	-0.38	0.57	0.49	-0.48	-0.06	0.17	0.25	0.2	-0.47	0.16	-0.74	-0.51		0.0
Accounts Payable	0.44	0.38	0.52	0.37	-0.36	-0.21	0.54	0.49	0.02	0.35	0.25	0.49	0.48	-0.29	0.36	0.4	0.55	0.57	0.48	0.4	0.31	0.02	0.2	0.27	0.0

Click cells to compare fundamentals

InspireMD Account Relationship Matchups

InspireMD balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	17.8M	39.7M	24.7M	47.6M	46.8M	49.1M
Other Current Liab	3.1M	3.0M	4.0M	4.5M	6.4M	6.7M
Total Current Liabilities	3.7M	4.3M	5.1M	6.0M	7.7M	4.4M
Total Stockholder Equity	12.2M	33.5M	17.4M	39.5M	36.1M	37.9M
Net Debt	(11.6M)	(10.8M)	(3.0M)	(9.6M)	(17.1M)	(16.3M)
Retained Earnings	(168.2M)	(183.1M)	(201.6M)	(221.5M)	(253.5M)	(240.8M)
Cash	12.6M	12.0M	4.6M	9.6M	18.9M	19.9M
Cash And Short Term Investments	12.6M	34.0M	17.8M	39.0M	34.6M	36.4M
Common Stock Shares Outstanding	1.5M	7.3M	7.9M	24.3M	41.9M	44.0M
Liabilities And Stockholders Equity	17.8M	39.7M	24.7M	47.6M	46.8M	49.1M
Other Stockholder Equity	180.3M	216.6M	219.0M	261M	289.6M	149.4M
Total Liab	5.6M	6.2M	7.3M	8.1M	10.7M	7.2M
Total Current Assets	15.3M	37.1M	21.3M	44.2M	40.5M	42.5M
Short Long Term Debt Total	999K	1.2M	1.6M	1.6M	1.8M	2.6M
Non Current Assets Total	2.4M	2.6M	3.3M	3.5M	6.3M	6.6M
Non Currrent Assets Other	725K	905K	856K	951K	1.6M	953.6K
Net Receivables	945K	1.4M	1.2M	1.8M	2.3M	2.4M
Non Current Liabilities Total	1.9M	1.8M	2.2M	2.1M	3.0M	2.1M
Inventory	1.4M	1.1M	1.6M	2.1M	2.6M	2.7M
Short Term Debt	400K	420K	419K	557K	501.3K	945.1K
Other Liab	729K	910K	1.1M	995K	1.1M	738.6K
Accounts Payable	236K	893K	659K	939K	1.3M	824.4K
Other Assets	586K	725K	905K	856K	984.4K	506K
Other Current Assets	334K	522K	655K	3.0M	1.1M	540.6K
Property Plant Equipment	547K	448K	1.7M	2.5M	2.8M	3.0M
Net Tangible Assets	5.4M	12.2M	33.5M	17.4M	20.0M	21.0M
Net Invested Capital	12.2M	33.5M	17.4M	39.5M	36.1M	21.4M

Pair Trading with InspireMD

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InspireMD position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InspireMD will appreciate offsetting losses from the drop in the long position's value.

Moving against InspireMD Stock

0.57	ELMD	Electromed Potential Growth	Pair Corr
0.52	VTAK	Catheter Precision	Pair Corr
0.41	EMBC	Embecta Corp	Pair Corr
0.31	ENOV	Enovis Corp	Pair Corr

The ability to find closely correlated positions to InspireMD could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InspireMD when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InspireMD - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InspireMD to buy it.

The correlation of InspireMD is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InspireMD moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InspireMD moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for InspireMD can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

InspireMD Historical Balance Sheet

InspireMD Inventory

2.7 Million

About InspireMD Balance Sheet Analysis

InspireMD Balance Sheet Chart

Total Assets

Cash And Short Term Investments

Capital Stock

Capital Lease Obligations

InspireMD balance sheet Correlations

InspireMD Account Relationship Matchups

High Positive Relationship

High Negative Relationship

InspireMD balance sheet Accounts

Pair Trading with InspireMD

Moving against InspireMD Stock

Additional Tools for InspireMD Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Property Plant And Equipment Gross	+ 0.99	Common Stock Shares Outstanding
Total Stockholder Equity	+ 0.98	Total Assets
Property Plant And Equipment Net	+ 0.98	Property Plant And Equipment Gross
Cash And Short Term Investments	+ 0.97	Total Assets
Total Current Assets	+ 0.97	Total Stockholder Equity

Other Stockholder Equity	- 0.93	Retained Earnings
Other Liab	- 0.85	Retained Earnings
Current Deferred Revenue	- 0.84	Other Stockholder Equity
Property Plant And Equipment Net	- 0.8	Retained Earnings
Net Debt	- 0.8	Total Stockholder Equity
Cash	- 0.79	Net Debt